Close menu

September 1st, 2022 | 12:29 CEST

BYD after Buffett shock - Better to bet on JinkoSolar and Meta Materials?

  • metamaterials
  • Innovations
  • Technology
  • Electromobility
Photo credits:

So, now it is done: Star investor Warren Buffett has sold shares in the Tesla hunter, BYD. Although it is only a small part of the investment, the BYD share went down significantly. Because now, the door is open to speculation about what will happen to the legal shares - Buffett's Berkshire Hathaway still holds almost 19% of the Chinese carmaker. The convincing quarterly figures have thus receded into the background. JinkoSolar has presented mixed figures. The Company is benefiting from the skyrocketing electricity and gas prices. After all, they are driving demand for solar systems, but analysts are divided. Meta Materials' innovative functional materials are also expected to revolutionize renewable energy production in the future. For further development, the patent octopus has now strengthened itself with a veteran of the chip industry.

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: BYD CO. LTD H YC 1 | CNE100000296 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007 , Meta Materials Inc. | US59134N1046

Table of contents:

    Uwe Ahrens, Director, Altech Advanced Materials AG
    "[...] We know exactly what we are doing and are implementing what we consider to be a proven technology in an industrially applicable and scalable way. [...]" Uwe Ahrens, Director, Altech Advanced Materials AG

    Full interview


    BYD: Buffett shock overshadows good figures

    For more than a month, there has been speculation that Warren Buffett's Berkshire Hathaway could divest itself of BYD shares. At the time, a BYD position equal in size to Berkshire's appeared in the Hong Kong stock clearing system under a Citibank account. A stock market report now shows that the stake in BYD fell from 20.49% to 19.92%. The block of shares sold was worth USD 47 million. Not much, but now, there is speculation as to what will happen to the remaining shares. Will more pieces be thrown on the market? Maybe Buffett will part with the entire stake?

    Buffett first took a stake in BYD in 2008. Since then, the share has increased more than twenty-fold. As a result of the report, the BYD share does not benefit from the otherwise good quarterly figures. BYD sold 355,021 vehicles (hybrid and all-electric) in the second quarter, 256% more than in the same period last year. Compared to the first quarter of the current year, the increase is still 24%. Sales increased by 68% YOY to CNY 83.77 billion. BYD is also making progress in terms of profitability. Thus, net profit climbed by 198% to around CNY 2.8 billion in the reporting period. Following the figures, Credit Suisse analysts raised their earnings estimates for the years up to 2024 by up to 40% and the price target to HKD 400. However, this could not slow down yesterday's selling pressure. In trading on the Hong Kong Stock Exchange yesterday, the share lost 12%.

    Meta Materials: Patent octopus brings chip veterans on board

    Operationally, Meta Materials is currently picking up speed. However, the technology company is still at a very early stage, and the focus is on research. Nevertheless, the Canadians, listed in Germany and on the NASDAQ, increased sales in the second quarter by 432% to USD 3.3 million. Meta Materials is working hard to develop high-performance functional materials and nanocomponents. One application example with huge market potential is early detection in the medical field - including strokes. According to the World Stroke Organization, stroke is the second leading cause of death worldwide. Meta Materials is working on a portable and low-cost radio wave imaging scanner. In this effort, Meta Materials aims to provide higher image resolution and faster scans than previous products, all without radiation. Meta's approach has been featured in several technical articles and has already been secured as a US patent. The patent covers a wide range of potential applications, including image detection of breast cancer, brain clots, and the diagnosis of internal bleeding.

    Meta Materials now has a total of 410 active patent documents - of which 251 are issued patents, and 159 are pending patent applications. In the future, high-performance materials with nanotechnology should make it possible to redirect light, sound, heat or radio waves. The potential is gigantic and spans all industries such as 5G communications, health and wellness, aerospace, the automotive industry and renewable energy. As the Company grows, it is also evolving in terms of personnel. For example, Jack Harding, the former executive of chip giant Advanced Micro Devices, was recently appointed Chairman of the Board. Harding is a true veteran of the chip industry. In addition to his time at AMD, he also oversaw the billion-dollar merger of RF Micro Devices and TriQuint Semiconductor to form Qorvo. Should the research and subsequent monetization be successful, a billion-dollar valuation could also be possible for Meta Materials. Currently, the market capitalization of the hot stock is around USD 280 million.

    JinkoSolar: Fair value at USD 71 or USD 35?

    JinkoSolar has already reached a market capitalization of over one billion. When looking at the current figures, however, there could be even more to it than the approximately USD 3.3 billion. This opinion is shared by analysts at BOC International, among others. The experts recommend the share of the Chinese solar cell and solar module producer with "Buy" and a price target of USD 71. In contrast, Goldman Sachs has renewed its sell recommendation. The analysts are skeptical about the coming quarters. Thus, JinkoSolar has problems with cash flow generation and the debt-equity ratio.

    Regarding the numbers: The Chinese company benefited from high demand for its solar modules in the second quarter. Solar modules with an output of 10,183 MW and cells and wafers with 349 MW were delivered. All in all, this was equivalent to around double the previous year's figure. Compared to the same period of the previous year, sales increased by 138% to USD 2.81 billion. However, JinkoSolar's results were disappointing, and the Company even slipped into the red. Thus, the net loss was USD 93 million, compared to a net profit of over USD 9 million in the same quarter last year. In the full year 2022, 35 to 40 GW (modules, cells and wafers) are to be delivered.

    BYD is in a top position operationally, but one should not underestimate the image damage from the Buffett sale. At the hotstock Meta Materials, the new chairman of the board of directors is creating an improved image. JinkoSolar must finally get a grip on profitability, which does not seem to be the case at the moment.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author

    Related comments:

    Commented by Juliane Zielonka on April 18th, 2024 | 07:00 CEST

    Volkswagen, Altech Advanced Materials, BYD - who can benefit from China's rise

    • Innovations
    • Technology
    • Electromobility
    • Batteries

    Chinese companies such as BYD benefit from state subsidies and domestic access to raw materials. BYD's subsidies have risen from EUR 220 million in just three years to EUR 2.1 billion. These sums are helping BYD dominate the Chinese electric vehicle market and increasingly penetrate the European market. Volkswagen cannot escape the pull of China either. As part of its "In China, for China" strategy, Volkswagen is expanding its cooperation network with Chinese partners. The aim is to reduce costs significantly in the development of EV technology. For companies like Altech Advanced Materials, close cooperation with Chinese market leaders such as BYD and Volkswagen offers the opportunity to commercialize innovative battery technologies that meet the needs of the changing market. One of these innovations, made in Germany by Altech Advanced Materials, increases the longevity of EV batteries by 30%. Here are the details.


    Commented by Juliane Zielonka on April 11th, 2024 | 07:45 CEST

    Innovation made in Europe: Singulus Technologies, Siemens Energy, BASF - which share offers the greatest potential?

    • renewableenergies
    • chemicals
    • Technology

    Companies in Europe, like Singulus Technologies, are leaders in the production of surface materials in future-oriented sectors such as photovoltaics, semiconductors, medical technology and cosmetics. This is reason enough to take a closer look at Europe as a location. The European Commission is determined to push ahead with CO₂ reduction with all its might and subsidize future energies. They would prefer to lock out Chinese companies that produce solar and wind turbines more cost-effectively than Siemens Energy. However, China is also an excellent place to do business. Chemical giant BASF strategically adheres to long-term contracts, in line with the Chinese strategist Sun Tzu. Which share offers the greatest potential for investors?


    Commented by André Will-Laudien on April 10th, 2024 | 06:45 CEST

    Attention: Biotech takeovers, after MorphoSys, now Bayer, Vidac Pharma, BioNTech and Pfizer are on the radar

    • Pharma
    • Biotechnology
    • Innovations

    Since the onset of the COVID-19 pandemic, there has been little movement in the biotech sector. However, after a challenging year in 2023, the sector was at least able to start the new year on a solid footing. The surprising takeover of MorphoSys recently got hearts beating again, as Novartis put a whopping EUR 2.7 billion on the table for the cancer specialist from Munich. Only months before, MorphoSys had been traded on the stock exchange at just EUR 700 million. The special market situation in this case was also characterized by the high short ratio, which led to an exorbitant rise in the share price of almost 400% in the final phase. Speculative investors are now keeping a wary eye on potential takeover candidates as the sector is once again attracting considerable attention. We are taking a closer look and searching for the next pearl.